Afficher la couverture 'Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy | Denis, Morgane' en grand format
/5

0 avis

Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy

Archive ouverte

Denis, Morgane | Mathé, Doriane | Micoud, Manon | Choffour, Pierre-Antoine | Grasselly, Chloé | Matera, Eva-Laure | Dumontet, Charles

Edité par CCSD ; Frontiers -

International audience. Introduction The use of tumor subcutaneous (SC) implantations rather than orthotopic sites is likely to induce a significant bias, in particular, in the field of immunotherapy.Methods: In this study, we developed and characterized MC38 models, implanted subcutaneously and orthotopically, which were either sensitive or rendered resistant to anti-PD1 therapy. We characterized the tumor immune infiltrate by flow cytometry at baseline and after treatment.Results and Discussion Our results demonstrate several differences between SC and orthotopic models at basal state, which tend to become similar after therapy. These results emphasize the need to take into account tumor implantation sites when performing preclinical studies with immunotherapeutic agents.

Suggestions

Du même auteur

In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies

Archive ouverte | Denis, Morgane | CCSD

International audience. Abstract Antibodies targeting PD-1 and PD-L1 have produced durable responses in a subset of patients with cancer. However, a majority of these patients will ultimately relapse due to acquired...

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models

Archive ouverte | Chettab, Kamel | CCSD

International audience. Bacterial lipopolysaccharides (LPS) are potent innate immunostimulants targeting the Toll-like receptor 4 (TLR4), an attractive and validated target for immunostimulation in cancer therapy. A...

Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies

Archive ouverte | Duong, Minh, Ngoc | CCSD

International audience. Targeted therapies of malignancies currently consist of therapeutic monoclonal antibodies and small molecule kinase inhibitors. The combination of these novel agents raises the issue of poten...

Chargement des enrichissements...